Why So Many on BP Meds Still Miss Target - Report - MDSpire
Advertisement
Why So Many on BP Meds Still Miss Target
Most U.S. adults with hypertension missed blood pressure targets—including those on treatment—highlighting gaps in initiation and intensification of therapy, new JAMA data show.
Clinical Report: Why So Many on BP Meds Still Miss Target
Overview
Revise to specify that nearly 80% of individuals on therapy still exceed targets.
Background
Hypertension is a prevalent condition affecting a large segment of the adult population, with serious implications for cardiovascular health. Despite the availability of antihypertensive medications, many patients fail to achieve target blood pressure levels, which can lead to increased morbidity and mortality. Understanding the factors contributing to this treatment gap is crucial for improving patient outcomes.
Data Highlights
Blood Pressure Control
Untreated Adults
Treated Adults
≥10 mmHg above goal
34.6%
52.6%
≥20 mmHg above goal
12.8%
24.7%
≥30 mmHg above goal
5.7%
10.8%
Key Findings
Nearly 80% of US adults with hypertension exceed recommended blood pressure thresholds.
61% of adults with uncontrolled blood pressure are not on antihypertensive medication.
Adults on medication are more likely to have significantly elevated blood pressure levels compared to untreated individuals.
Many untreated adults with uncontrolled BP are within 10 mmHg of target levels, suggesting potential for improvement with treatment.
Older adults with comorbidities are more likely to be on antihypertensive therapy but still miss targets.
Clinical Implications
List specific lifestyle changes, such as diet and exercise, that could aid in BP control.
Conclusion
The findings underscore the importance of addressing treatment gaps in hypertension management, particularly among those already receiving therapy. Enhanced strategies for monitoring and adjusting treatment are essential for improving blood pressure control.